Loading…

Gecina SAGFC.PACompetitor analysis, valuation and peers

France · EUR·Real Estate›Real Estate Investment Trusts

French REIT focused on prime Paris-region office buildings and some residential/healthcare property.

Momentum neutral 48
Mkt cap
$5.47B
US dollars, full cap
Free float
96%
of shares outstanding
$/day
$15.2M
20-day average traded
P/B
0.48×
price to book
ROE
1.6%
delivered
Implied ROE
6.9%
what the price asks
Official | Implied
A- / BBB+
agencies · bond market
Next earnings
96 days
10 Feb 2027
Close · EUR€65.95
1D+0.5%
1W+2.6%
1M+9.6%
3M-11.7%
6M-8.2%
YTD-18.5%
1Y-18.5%
ATR %1.9%
52w lowhigh20.7% off high

What Gecina does

French REIT focused on prime Paris-region office buildings and some residential/healthcare property.

Collects rent under multi-year office leases indexed to official French price measures, so rents rise with inflation, and recycles capital by selling older or smaller buildings and developing or renovating others. Its offices are concentrated in central Paris and the western business districts. As a French REIT it is largely exempt from corporate tax on rental profits in return for paying most of them out.

Products and services

  • Prime Paris office buildings
  • Residential properties
  • Healthcare real estate

Customers

  • Corporate office tenants in Paris region

Where it sits in the supply chain

  • Real Estate
  • REIT
  • Office property ownership

What could go right

  • Paris prime office rent growth
  • Flight-to-quality office demand

What could go wrong

  • Office demand structural risk (remote work)
  • Interest rate sensitivity (REIT financing)

Moat: narrow (installed base, scale). Concentrated portfolio of prime, well-located Paris office assets commands premium rents.

Headquarters: Paris, France · Founded: 1959 · Employees: 442

Named competitors

Gecina at a glance

Size Gecina (GFC.PA) is a France Real Estate company (Real Estate Investment Trusts) with a market value of $5.47B, the 65th largest of 206 France companies the cockpit tracks. Shares closed at €65.95 on 6 Nov 2026.

Performance Over six months the shares fell 8.2%, against -2.2% for the median peer and -0.4% for the France market (cap-weighted) — 5th lowest of 21 in its peer set.

Growth Revenue grew 0.8% over the last twelve months (peer median +6.6%); the operating margin is 68.5% (peer median 33.8%).

Valuation It trades at 0.48× book value against a peer median of 1.31× (cheapest of 21).

Price implies The share price implies a return on equity of about 6.9%; Gecina delivers 1.6%, so the price asks more than the business earns today.

Credit Gecina has 10 bonds outstanding ($6.49B), rated A- by the agencies and trading like BBB+ at a weighted spread of 102 bp.

Next results Next results expected around 10 Feb 2027 (exchange calendar; dates can move).

Relative performance

9010011 May 202611 Aug 20266 Nov 2026Peer median 98GFC.PA 93
Six months, rebased to 100: Gecina against the median of its 20 peers (local-currency closes).

Gecina financials

Reported figures in EUR; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue€887M€867M€863M€843M€772M
Revenue growth—+1%+2%+9%—
Gross profit€692M€661M€640M€610M€570M
EBITDA€617M€656M€566M€536M€493M
Net income€162M€448M€310M-€1.79B€170M
Free cash flow-€94.9M-€120M€79.0M€224M€158M
Capital expenditure€567M€515M€455M€231M€241M
Total debtn/a€6.88B€6.71B€6.39B€7.23B

Quarterly statements and history in the cockpit →

Gecina competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-10%0%+10%0%+5%+10%+15%SBRAOUTCOVMGRCSH-UNPECORITMBLNDKRG8952N2IU8953CUZLMPEPRTGGCAJBURYNHRCOLDGFC.PA6-month return →1-month return →
Up and to the right = strong over both horizons. Gecina is the large dot.

Fundamentals: return on equity against price-to-book

0%5%10%15%10×20×30×40×SBRAOUTCOVMGRCSH-UNPECORITMBLNDKRG8952N2IU8953CUZGGCAJBURYNHRCOLDGFC.PAReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Gecina is the large dot.

Capital: ROE delivered against the ROE the price implies

0%25%50%75%0%50%SBRAOUTCOVMGRCSH-UN8952HRCOLDGFC.PAROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Gecina is the large dot.

Gecina competitors and peer comparison

Head to head with its named competitors (GFC.PA vs COV.PA vs URW.PA vs ICAD.PA)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
Gecina GFC.PA$5.47B-8%+1%2%0.48×6.9%
Covivio COV.PA$5.64B-16%+5%8%0.59×8.2%
Unibail-Rodamco-Westfield SE Stapled Secs Cons of 1 Sh Unibail Rodamco + 1 Sh WFD Unib Rod URW.PAn/a-7%n/an/an/an/a
Icade ICAD.PA$1.33B-22%-9%-5%0.33×5.4%

How Gecina compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Gecina against its 20 peers (data as of 6 Nov 2026)
MeasureGFC.PAPeer medianRank in peer set
1-month return+9.6%+7.5%8th highest of 21
6-month return-8.2%-2.2%5th lowest of 21
Return on equity1.6%6.7%5th lowest of 21
Price / book0.48×1.31×cheapest of 21
Trailing P/E30.2×21.8×5th most expensive of 19
ROE the price implies6.9%11.5%5th least demanding of 21
ROE delivered1.6%6.7%5th lowest of 20
Bond spread102 bp111 bp4th tightest of 14

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Gecina GFC.PAFrance$5.47B-8%+1%2%0.48×6.9%1.6%
Sabra Health Care REIT SBRAUnited States$5.51B+1%+21%3%1.94×13.0%2.5%
OUTFRONT Media OUTUnited States$5.42B-9%+8%36%7.82×77.8%36.2%
Covivio COV.PAFrance$5.64B-16%+5%8%0.59×8.2%7.9%
Mirvac MGR.AXAustralia$5.27B+14%+6%7%0.83×9.9%7.4%
Chartwell Retirement Residences CSH-UN.TOCanada$5.25B+3%+24%1%3.92×22.6%0.5%
Phillips Edison & PECOUnited States$5.72B+2%+7%8%2.17×12.9%7.8%
Rithm Capital RITMUnited States$5.15B-6%+19%6%0.74×8.7%5.6%
British Land BLND.LUnited Kingdom$5.94B+17%+15%8%0.73×11.6%7.8%
Kite Realty Group Trust KRGUnited States$5.04B-4%-7%12%1.84×14.6%11.5%
Japan Real Estate Investment 8952.TJapan$4.98B-10%-1%7%1.41×6.1%6.7%
Mapletree Pan Asia Commercial Trust N2IU.SISingapore$4.89B-7%-5%3%0.68×5.0%2.8%
Japan Metropolitan Fund Investment 8953.TJapan$4.87B-8%0%7%1.17×4.8%7.1%
Cousins Properties CUZUnited States$4.87B+11%+8%0%1.10×11.4%0.3%
LondonMetric Property LMP.LUnited Kingdom$6.16B+2%+17%7%0.93×12.6%6.7%
Essential Properties Realty Trust EPRTUnited States$6.21B-11%+21%6%1.36×11.1%6.3%
General de Galerias Comerciales GGC.MCSpain$4.70B0%+3%18%3.99×13.5%n/a
Keppel DC REIT AJBU.SISingapore$4.67B-6%+30%11%1.26×6.8%11.4%
Rayonier RYNUnited States$6.45B+6%-13%2%1.23×10.9%2.0%
Healthcare Realty Trust HRUnited States$6.50B-5%-6%-2%1.56×11.9%-2.0%
Americold Realty Trust COLDUnited States$4.57B+8%0%-16%1.89×15.5%-16.5%

Gecina bonds and credit

Gecina has 10 bonds outstanding with $6.49B face value. The agencies rate it A-; its bonds trade like BBB+. Weighted yield 4.20%, a spread of 102 bp over government bonds.

Every bond, yield and spread in the cockpit →

Questions

Who are Gecina's main competitors?
Named competitors: Covivio (COV.PA), Unibail-Rodamco-Westfield (URW.PA), Icade (ICAD.PA). The cockpit's measured peer set (industry) also includes Sabra Health Care REIT (SBRA), OUTFRONT Media (OUT), Covivio (COV.PA), Mirvac (MGR.AX), Chartwell Retirement Residences (CSH-UN.TO), Phillips Edison & (PECO).
Is Gecina expensive compared with its peers?
On price / book it trades at 0.48× against a peer median of 1.31×, cheapest of 21 in its peer set. The share price implies a return on equity of about 6.9%; Gecina delivers 1.6%, so the price asks more than the business earns today.
How has Gecina stock performed?
Over six months to 6 Nov 2026 the shares returned -8.2% against -2.2% for the median peer; over one year -18.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.